• Explore /
  • Poster
  • / Preliminary results for the advanced salivary gland carcinoma cohort of the phase 1b KEYNOTE-028 study of pembrolizumab.

Preliminary results for the advanced salivary gland carcinoma cohort of the phase 1b KEYNOTE-028 study of pembrolizumab.

Abstract Poster

Authors

Roger Cohen

Roger B. Cohen

University of Pennsylvania, Philadelphia, PA

Roger B. Cohen , Jean-Pierre Delord , Toshihiko Doi , Sarina Anne Piha-Paul , Stephen V. Liu , Jill Gilbert , Alain Patrick Algazi , Sara Cresta , Ruey-Long Hong , Christophe Le Tourneau , Daphne Day , Andrea Varga , Elena Elez , John M. Wallmark , Sanatan Saraf , Anne Morosky , Jonathan D. Cheng , Bhumsuk Keam

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Other Head and Neck Cancer (Salivary, Thyroid)

Clinical Trial Registration Number

NCT02054806

Citation

J Clin Oncol 34, 2016 (suppl; abstr 6017)

DOI

10.1200/JCO.2016.34.15_suppl.6017

Abstract #

6017

Poster Bd #

339

Abstract Disclosures

Similar Posters

First Author: Timothy Jay Price

First Author: Janice M. Mehnert

First Author: Julio Antonio Peguero

Poster

2016 ASCO Annual Meeting

Pembrolizumab in advanced endometrial cancer: preliminary results from the phase 1b KEYNOTE-028 study.

Pembrolizumab in advanced endometrial cancer: preliminary results from the phase 1b KEYNOTE-028 study.

First Author: Patrick Alexander Ott